• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Ocular Therapeutix Inc

Ocular Therapeutix dips on Q3 losses

November 12, 2019 By Sean Whooley

Ocular Therapeutix logo

Ocular Therapeutix (NSDQ:OCUL) shares fell today on third-quarter results that narrowly topped the consensus forecast despite a bottom-line dip. The Bedford, Mass.–based ophthalmic insert maker posted losses of -$18,778, or -45¢ per share, on sales of $829,000 for the three months ended Sept. 30, for a 25.1% bottom-line slide on sales growth of 66.5%. Adjusted to […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Optical/Ophthalmic Tagged With: Ocular Therapeutix, Ocular Therapeutix Inc

Ocular Therapeutix launches Phase III trial for eye plug

March 19, 2014 By drugdelivery

Ocular Therapeutix launches Phase III trial for eye plug

Bedford, mass.-based Ocular Therapeutix launched Phase III human clinical studies of its drug-releasing optical plug in patients undergoing cataract surgery.

Filed Under: Drug-Device Combinations Tagged With: Clinical Trials, Ocular Therapeutix Inc

Baxter buys stake in Ocular Therapeutix

June 10, 2013 By Brad Perriello

Baxter buys stake in Ocular Therapeutix

Baxter‘s (NYSE:BAX) venture capital arm bought a minority stake in Ocular Therapeutix and its slate of ophthalmic products, part of an $8.5 million funding round that also included existing backer Ascension Health Ventures.

Filed Under: Drug-Device Combinations Tagged With: Ascension Health Ventures, Baxter International, Ocular Therapeutix Inc

Ocular Therapeutix closes enrollment in Phase II study of tear duct plug

June 4, 2013 By drugdelivery

OcularTherapeutix

Ocular Therapeutix wrapped up patient enrollment for a Phase II trial evaluating the company’s OTX-DP tear duct plug, the company announced this week.

Filed Under: Drug-Device Combinations Tagged With: Clinical Trials, Ocular Therapeutix Inc

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS